Nutra Pharma Corp.'s latest marketcap:

About Nutra Pharma Corp.

Nutra Pharma Corp. is a biopharmaceutical company focused on acquiring, licensing, and commercializing pharmaceutical products and technologies. The company specializes in homeopathic and ethical drugs designed to manage pain, neurological disorders, cancer, and autoimmune and infectious diseases, primarily serving the U.S. market.

Key Products

• Nyloxin & Nyloxin Extra Strength: Oral sprays and topical gels for pain relief, including lower back pain, migraines, arthritis, and neuropathic pain.
• Pet Pain-Away: A non-narcotic, non-addictive homeopathic pain reliever for companion animals.
• Luxury Feet: An OTC anti-inflammatory product for foot pain caused by high heels and stilettos.
• Nyloxin Military Strength: A specialized pain relief solution for U.S. Military and Veteran's Administration use.
• Equine Pain-Away: A topical pain reliever for horses.

Research & Development

Nutra Pharma is actively developing innovative treatments, including:

• RPI-78M: Targeting neurological and autoimmune diseases such as multiple sclerosis, ALS, and rheumatoid arthritis.
• RPI-MN: Focused on viral diseases like HIV/AIDS and herpes, with broader antiviral applications.
• RPI-78 & RPI-70: Designed for pain and arthritis management.

Founded: 2000 | Headquarters: Plantation, Florida